scopic examination was performed with a colonoscope, the sigmoid colon revealed edematous and erosive mucosa only (Fig. 1 ). Due to diarrhea-induced bowel cleansing, the colonoscope was able to be advanced proximally into the terminal ileum, which showed multiple yellowish plaques only in the cecal mucosa (Fig. 2) . Biopsy specimen of the cecum revealed disruption of surface epithelium with an overlying mushroom-shaped pseudomembrane which was compatible with the findings of PMC (Fig. 3) . After colonoscopy, the stool assay for C. difficile toxin came out to be positive but stool culture for C.difficile was negative. Oral metronidazole (1,500 mg/ day) was started and anti-TB agents excluding rifampin were readministerd 2 days after the initiation of metronidazole. His symptoms improved remarkably the day after taking the medications and did not recur since then.
DISCUSSION
PMC is a characteristic manifestation of full blown C. difficile infection, which is acquired almost exclusively in association with the use of antimicrobials and the consequent disruption of the normal colonic flora. Various antibiotics, including lincomycin, clindamycin, and ß-lactam compunds are well known causative agents of PMC. On the other hand, anti-TB agents are uncommon cause of PMC and a few cases of anti-TB agents-related PMC have been described since the 1980s. [6] [7] [8] [9] Although it is still controversial whether rifampin can be a causative agent, rifampin has been postulated to be one of the causes because it has antibacterial activity on a broad spectrum of bacteria whereas isoniazid, pyrazinamide, and ethambutol do not have antibacterial activity to disturb the normal intestinal flora. 10 Besides the broad spectrum of antibacterial activity, frequent isolation of rifampin-resistant toxigenic C. difficile also implies that rifampin could be the causative agent. 11, 12 In the present case, given the temporal relationship between anti-TB medications and the onset of symptoms, it is suspected that PMC was associated with anti-TB agents. Additionally, the patient' s symptoms did not recur after rechallenging the rest of anti-TB agents except for rifampin, which demonstrates that rifampin caused PMC in our case.
The identified risk factors for PMC include advanced age, immunocompromised state, hospitalization, and procedures or medications that alter the intestinal motility or flora. 13 The median age of rifampin-induced PMC was 59.5 years, which is younger than that of usual PMC patients. 4 Our patient was older than most of the reported cases, although he did not have other risk factors. Rifampin-induced PMC was also associated with moderate-to-severe liver dysfunction. 7, 10, 14 It is thought that liver dysfunction results in reduced biliary excretion of rifampin, which causes high concentration of serum levels and/ or low intestinal rifampin levels. 8, 14 The clinical presentations of PMC include diarrhea, abdominal pain, fever, and leukocytosis. Most patients develop PMC after 5 to 10 days of antibiotic treatment. However, in rifampin-associated PMC, the median latency period was 4 weeks, longer than the commonly known causes of PMC, 4 which reflects that rifampin may have less capacity to perturb the intestinal bacterial flora than other antibiotics such as ß-lactam compounds and clindamycin. 10 The latency of our patient' s clinical symptom was about 2 weeks, which was shorter than that of previously reported cases. 4, 15 The confirmative diagnosis of PMC is either positive stool culture or positive stool toxin assay for C. difficile with clinical data. However, sigmoidoscopy, colonoscopy or abdominal computed tomography scan can provide useful diagnostic information. PMC is commonly localized to the rectum and sigmoid colon. Thus, sigmoidoscopy is usually sufficient to detect typical findings of PMC such as the pseudomembrane. However, there are reports of rectal or rectosigmoid sparing PMC occuring in as many as 23% to 69% of patients. 16, 17 Normal mucosal appearance or nonspecific proctosigmoiditis may be the sigmoidoscopic finding but pseudomembrane can be found in ascending colon as occurred in our case. Therefore, total colonoscopy should be performed to confirm the diagnosis of PMC, if sigmoidoscopy is inconclusive. The test for resistant strain of C. difficile is needed for the investigation of causative agent of PMC in a patient suspected to have rifampinassociated PMC. In our case, however, the test for rifampin resistance could not be performed due to negative stool culture of C. difficile.
Once PMC is diagnosed, it is usually treated with oral metronidazole 500 mg t.i.d. or 250 mg q.i.d. for 10 days. 18 Besides antibiotic therapy, restoration of beneficial intestinal flora with probiotics may suppress the abnormal overgrowth of C. difficile and thus ameliorate the course of the disease. In our case, watery diarrhea was disappeared with metronidazole therapy, although the discontinuation of all anti-TB medications did not affect his symptom. However, it was recently reported in Korea that anti-TB agents induced PMC was treated with maintenance of the anti-TB medications and the addition of both oral metronidazole and probiotics. 15 In conclusion, our case reinforces the concept that rifampin can be one of the causes of PMC and reveals that rifampininduced PMC can be presented as a localized disease with rectosigmoid sparing. Thus, total colonoscopy is needed for the differential diagnosis in patients with severe diarrhea developing during or after anti-TB treatment, if sigmoidoscopy is not confirmative.
